c-Yes activation promotes the growth and tumor formation of β-catenin-active CRC cell lines by promoting the expression of BIRC5 and BCL2L1, the transcriptional targets of the β-catenin/Yes-associated protein 1 (YAP1)/TBX5 complex. The gene discussed is YES1; the disease is neoplasm.